Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Inoue

Showing results (261-270 of 305) with videos related to

Pageof 31
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|October 29, 2020
Clinical Risk Factors and Prognostic Impact of Osteoporosis in Patients With Chronic Heart FailureSatoshi Katano, Toshiyuki Yano, Takanori Tsukada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2014
Adalimumab for the treatment of Japanese patients with intestinal Behçet's diseaseSatoshi Tanida, Nagamu Inoue, Kiyonori Kobayashi, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 5, 2021
Energy intake during hospital stay predicts all-cause mortality after discharge independently of nutritional status in elderly heart failure patientsSatoshi Katano, Toshiyuki Yano, Hidemichi Kouzu, et al.
Digestion|June 15, 2022
Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative ColitisSatoshi Nakata, Kazuki Kakimoto, Keijiro Numa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2018
Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief ReportYuki Owada-Ozaki, Satoshi Muto, Hironori Takagi, et al.
Lung|January 24, 2024
Efficacy and Safety of Re-administration of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) After EGFR-TKI-Induced Interstitial Lung Disease (CS-Lung-005)Nobuhiro Kanaji, Eiki Ichihara, Takaaki Tanaka, et al.
Intestinal Research|August 12, 2025
Real-world effectiveness and safety of carotegrast methyl in patients with ulcerative colitis: a multicenter retrospective cohort studyRyoji Koshiba, Kazuki Kakimoto, Takuya Inoue, et al.
Cancer Immunology, Immunotherapy : CII|December 7, 2019
Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancerYuki Ozaki, Satoshi Muto, Hironori Takagi, et al.
Surgical Endoscopy|December 19, 2022
Diagnostic value of endoscopic ultrasonography for the depth of gastric cancer suspected of submucosal invasion: a multicenter prospective studyYoshiki Tsujii, Yoshito Hayashi, Ryu Ishihara, et al.
Thoracic Cancer|October 17, 2024
Efficacy of immune checkpoint inhibitors according to programmed cell death-ligand 1 expression in patients with non-small cell lung cancer and brain metastasis: A real-world prospective observational studyTakeshi Masuda, Yukari Tsubata, Kojirou Hata, et al.
Pageof 31

Showing results (261-270 of 305) with videos related to

Sort By:
Pageof 31
Circulation Journal : Official Journal of the Japanese Circulation Society|October 29, 2020
Clinical Risk Factors and Prognostic Impact of Osteoporosis in Patients With Chronic Heart FailureSatoshi Katano, Toshiyuki Yano, Takanori Tsukada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2014
Adalimumab for the treatment of Japanese patients with intestinal Behçet's diseaseSatoshi Tanida, Nagamu Inoue, Kiyonori Kobayashi, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 5, 2021
Energy intake during hospital stay predicts all-cause mortality after discharge independently of nutritional status in elderly heart failure patientsSatoshi Katano, Toshiyuki Yano, Hidemichi Kouzu, et al.
Digestion|June 15, 2022
Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative ColitisSatoshi Nakata, Kazuki Kakimoto, Keijiro Numa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2018
Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief ReportYuki Owada-Ozaki, Satoshi Muto, Hironori Takagi, et al.
Lung|January 24, 2024
Efficacy and Safety of Re-administration of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) After EGFR-TKI-Induced Interstitial Lung Disease (CS-Lung-005)Nobuhiro Kanaji, Eiki Ichihara, Takaaki Tanaka, et al.
Intestinal Research|August 12, 2025
Real-world effectiveness and safety of carotegrast methyl in patients with ulcerative colitis: a multicenter retrospective cohort studyRyoji Koshiba, Kazuki Kakimoto, Takuya Inoue, et al.
Cancer Immunology, Immunotherapy : CII|December 7, 2019
Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancerYuki Ozaki, Satoshi Muto, Hironori Takagi, et al.
Surgical Endoscopy|December 19, 2022
Diagnostic value of endoscopic ultrasonography for the depth of gastric cancer suspected of submucosal invasion: a multicenter prospective studyYoshiki Tsujii, Yoshito Hayashi, Ryu Ishihara, et al.
Thoracic Cancer|October 17, 2024
Efficacy of immune checkpoint inhibitors according to programmed cell death-ligand 1 expression in patients with non-small cell lung cancer and brain metastasis: A real-world prospective observational studyTakeshi Masuda, Yukari Tsubata, Kojirou Hata, et al.
Pageof 31